Journal article 503 views 137 downloads
Odd chain fatty acid metabolism in mice after a high fat diet
The International Journal of Biochemistry & Cell Biology, Volume: 143, Start page: 106135
Swansea University Author: Helen Griffiths
-
PDF | Version of Record
© 2021 The Author(s). This is an open access article under the CC BY license
Download (3.05MB)
DOI (Published version): 10.1016/j.biocel.2021.106135
Abstract
Epidemiological studies show that higher circulating levels of odd chain saturated fatty acids (FA: C15:0 and C17:0) are associated with lower risk of metabolic disease. These odd chain saturated fatty acids (OCSFA) are produced by α-oxidation in peroxisomes, de novo lipogenesis, from the diet and b...
Published in: | The International Journal of Biochemistry & Cell Biology |
---|---|
ISSN: | 1357-2725 |
Published: |
Elsevier BV
2022
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa59403 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2022-02-15T15:06:34Z |
---|---|
last_indexed |
2023-01-11T14:40:39Z |
id |
cronfa59403 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-08-08T15:19:31.0612510</datestamp><bib-version>v2</bib-version><id>59403</id><entry>2022-02-15</entry><title>Odd chain fatty acid metabolism in mice after a high fat diet</title><swanseaauthors><author><sid>0366ea9a689b222146b7d63c6baf8427</sid><firstname>Helen</firstname><surname>Griffiths</surname><name>Helen Griffiths</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-02-15</date><deptcode>SMT</deptcode><abstract>Epidemiological studies show that higher circulating levels of odd chain saturated fatty acids (FA: C15:0 and C17:0) are associated with lower risk of metabolic disease. These odd chain saturated fatty acids (OCSFA) are produced by α-oxidation in peroxisomes, de novo lipogenesis, from the diet and by gut microbiota. Although present at low concentrations, they are of interest as potential targets to reduce metabolic disease risk. To determine whether OCSFA are affected by obesogenic diets, we have investigated whether high dietary fat intake affects the frequency of OCSFA-producing gut microbiota, liver lipid metabolism genes and circulating OCSFA. FA concentrations were determined in liver and serum from pathogen-free SPF C57BL/6 J mice fed either standard chow or a high fat diet (HFD; 60% calories as fat) for four and twelve weeks. Post-mortem mouse livers were analysed histologically for fat deposition by gas chromatography–mass spectrometry for FA composition and by qPCR for the lipid metabolic genes fatty acid desaturase 2 (FADS2), stearoyl CoA desaturase 1 (SCD1), elongation of long-chain fatty acids family member 6 (ELOVL6) and 2-hydroxyacyl-CoA lyase 1 (HACL). Gut microbiota in faecal pellets from the ileum were analysed by 16S RNA sequencing. A significant depletion of serum and liver C15:0 (>50%; P < 0.05) and liver C17:0 (>35%; P < 0.05) was observed in HFD-fed SPF mice in parallel with hepatic fat accumulation after four weeks. In addition, liver gene expression (HACL1, ELOVL6, SCD1 and FADS2) was lower (>50%; P < 0.05) and the relative abundance of beneficial C3:0-producing gut bacteria such as Akkermansia, Lactobacillus, Bifidobacterium was lower after HFD in SPF mice. In summary, high dietary fat intake reduces serum and liver OCSFA, OCSFA-producing gut microbiota and is associated with impaired liver lipid metabolism. Further studies are required to identify whether there is any beneficial effect of OCSFA and C3:0-producing gut bacteria to counter metabolic disease.</abstract><type>Journal Article</type><journal>The International Journal of Biochemistry & Cell Biology</journal><volume>143</volume><journalNumber/><paginationStart>106135</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1357-2725</issnPrint><issnElectronic/><keywords>Free fatty acids; Gut microbiota; Odd-chain saturated fatty acids; Steatosis; Liver</keywords><publishedDay>1</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-02-01</publishedDate><doi>10.1016/j.biocel.2021.106135</doi><url/><notes/><college>COLLEGE NANME</college><department>Senior Leadership Team</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>SMT</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-08-08T15:19:31.0612510</lastEdited><Created>2022-02-15T15:01:23.2346084</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Isaac</firstname><surname>Ampong</surname><order>1</order></author><author><firstname>O. John</firstname><surname>Ikwuobe</surname><order>2</order></author><author><firstname>James E.P.</firstname><surname>Brown</surname><order>3</order></author><author><firstname>Clifford J.</firstname><surname>Bailey</surname><order>4</order></author><author><firstname>Dan</firstname><surname>Gao</surname><order>5</order></author><author><firstname>Jorge</firstname><surname>Gutierrez-Merino</surname><order>6</order></author><author><firstname>Helen</firstname><surname>Griffiths</surname><order>7</order></author></authors><documents><document><filename>59403__22496__d9b89310c60142d7818444795a3b2b6f.pdf</filename><originalFilename>59403.pdf</originalFilename><uploaded>2022-03-02T14:31:38.1725504</uploaded><type>Output</type><contentLength>3199977</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2021 The Author(s). This is an open access article under the CC BY license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-08-08T15:19:31.0612510 v2 59403 2022-02-15 Odd chain fatty acid metabolism in mice after a high fat diet 0366ea9a689b222146b7d63c6baf8427 Helen Griffiths Helen Griffiths true false 2022-02-15 SMT Epidemiological studies show that higher circulating levels of odd chain saturated fatty acids (FA: C15:0 and C17:0) are associated with lower risk of metabolic disease. These odd chain saturated fatty acids (OCSFA) are produced by α-oxidation in peroxisomes, de novo lipogenesis, from the diet and by gut microbiota. Although present at low concentrations, they are of interest as potential targets to reduce metabolic disease risk. To determine whether OCSFA are affected by obesogenic diets, we have investigated whether high dietary fat intake affects the frequency of OCSFA-producing gut microbiota, liver lipid metabolism genes and circulating OCSFA. FA concentrations were determined in liver and serum from pathogen-free SPF C57BL/6 J mice fed either standard chow or a high fat diet (HFD; 60% calories as fat) for four and twelve weeks. Post-mortem mouse livers were analysed histologically for fat deposition by gas chromatography–mass spectrometry for FA composition and by qPCR for the lipid metabolic genes fatty acid desaturase 2 (FADS2), stearoyl CoA desaturase 1 (SCD1), elongation of long-chain fatty acids family member 6 (ELOVL6) and 2-hydroxyacyl-CoA lyase 1 (HACL). Gut microbiota in faecal pellets from the ileum were analysed by 16S RNA sequencing. A significant depletion of serum and liver C15:0 (>50%; P < 0.05) and liver C17:0 (>35%; P < 0.05) was observed in HFD-fed SPF mice in parallel with hepatic fat accumulation after four weeks. In addition, liver gene expression (HACL1, ELOVL6, SCD1 and FADS2) was lower (>50%; P < 0.05) and the relative abundance of beneficial C3:0-producing gut bacteria such as Akkermansia, Lactobacillus, Bifidobacterium was lower after HFD in SPF mice. In summary, high dietary fat intake reduces serum and liver OCSFA, OCSFA-producing gut microbiota and is associated with impaired liver lipid metabolism. Further studies are required to identify whether there is any beneficial effect of OCSFA and C3:0-producing gut bacteria to counter metabolic disease. Journal Article The International Journal of Biochemistry & Cell Biology 143 106135 Elsevier BV 1357-2725 Free fatty acids; Gut microbiota; Odd-chain saturated fatty acids; Steatosis; Liver 1 2 2022 2022-02-01 10.1016/j.biocel.2021.106135 COLLEGE NANME Senior Leadership Team COLLEGE CODE SMT Swansea University 2022-08-08T15:19:31.0612510 2022-02-15T15:01:23.2346084 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Isaac Ampong 1 O. John Ikwuobe 2 James E.P. Brown 3 Clifford J. Bailey 4 Dan Gao 5 Jorge Gutierrez-Merino 6 Helen Griffiths 7 59403__22496__d9b89310c60142d7818444795a3b2b6f.pdf 59403.pdf 2022-03-02T14:31:38.1725504 Output 3199977 application/pdf Version of Record true © 2021 The Author(s). This is an open access article under the CC BY license true eng http://creativecommons.org/licenses/by/4.0/ |
title |
Odd chain fatty acid metabolism in mice after a high fat diet |
spellingShingle |
Odd chain fatty acid metabolism in mice after a high fat diet Helen Griffiths |
title_short |
Odd chain fatty acid metabolism in mice after a high fat diet |
title_full |
Odd chain fatty acid metabolism in mice after a high fat diet |
title_fullStr |
Odd chain fatty acid metabolism in mice after a high fat diet |
title_full_unstemmed |
Odd chain fatty acid metabolism in mice after a high fat diet |
title_sort |
Odd chain fatty acid metabolism in mice after a high fat diet |
author_id_str_mv |
0366ea9a689b222146b7d63c6baf8427 |
author_id_fullname_str_mv |
0366ea9a689b222146b7d63c6baf8427_***_Helen Griffiths |
author |
Helen Griffiths |
author2 |
Isaac Ampong O. John Ikwuobe James E.P. Brown Clifford J. Bailey Dan Gao Jorge Gutierrez-Merino Helen Griffiths |
format |
Journal article |
container_title |
The International Journal of Biochemistry & Cell Biology |
container_volume |
143 |
container_start_page |
106135 |
publishDate |
2022 |
institution |
Swansea University |
issn |
1357-2725 |
doi_str_mv |
10.1016/j.biocel.2021.106135 |
publisher |
Elsevier BV |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
Epidemiological studies show that higher circulating levels of odd chain saturated fatty acids (FA: C15:0 and C17:0) are associated with lower risk of metabolic disease. These odd chain saturated fatty acids (OCSFA) are produced by α-oxidation in peroxisomes, de novo lipogenesis, from the diet and by gut microbiota. Although present at low concentrations, they are of interest as potential targets to reduce metabolic disease risk. To determine whether OCSFA are affected by obesogenic diets, we have investigated whether high dietary fat intake affects the frequency of OCSFA-producing gut microbiota, liver lipid metabolism genes and circulating OCSFA. FA concentrations were determined in liver and serum from pathogen-free SPF C57BL/6 J mice fed either standard chow or a high fat diet (HFD; 60% calories as fat) for four and twelve weeks. Post-mortem mouse livers were analysed histologically for fat deposition by gas chromatography–mass spectrometry for FA composition and by qPCR for the lipid metabolic genes fatty acid desaturase 2 (FADS2), stearoyl CoA desaturase 1 (SCD1), elongation of long-chain fatty acids family member 6 (ELOVL6) and 2-hydroxyacyl-CoA lyase 1 (HACL). Gut microbiota in faecal pellets from the ileum were analysed by 16S RNA sequencing. A significant depletion of serum and liver C15:0 (>50%; P < 0.05) and liver C17:0 (>35%; P < 0.05) was observed in HFD-fed SPF mice in parallel with hepatic fat accumulation after four weeks. In addition, liver gene expression (HACL1, ELOVL6, SCD1 and FADS2) was lower (>50%; P < 0.05) and the relative abundance of beneficial C3:0-producing gut bacteria such as Akkermansia, Lactobacillus, Bifidobacterium was lower after HFD in SPF mice. In summary, high dietary fat intake reduces serum and liver OCSFA, OCSFA-producing gut microbiota and is associated with impaired liver lipid metabolism. Further studies are required to identify whether there is any beneficial effect of OCSFA and C3:0-producing gut bacteria to counter metabolic disease. |
published_date |
2022-02-01T04:16:41Z |
_version_ |
1763754116413128704 |
score |
11.037056 |